Part I. Design of a novel class of reversible non-covalent small
molecule inhibitors for human Granzyme B (hGrB)
Part II. Curcumin and mimics as proteasome inhibitors
Part III. Design of novel coactivator binding inhibitors (CBIs)
for the estrogen receptor α : break the 1µM barrier
1 of 10
Development of a novel stereo-selective synthetic route towards
Pumiliotoxin C, potent neurotoxin, via asymmetric
Diels-Alder and sequential protonation-nucleophilic addition as key
reaction steps
2 of 10
I: Expanding Genetic Code in S. cevevisiae with an
Orthogonal tRNATrp/UCA/ Tryptophanyl tRNA Synthetase
Pair II: Synthetic Yeast Prions based on a Non-NQ-rich
Amyloidogenic Sequence Derived from the NAC Protein Sequence of
α-Synuclein.
3 of 10
Conditional Deoxyribozyme Gene Knockdown: Investigating DNA
Displacement Reactions on Gold Nanoparticles
4 of 10
Synthesis, Characterization, and Dioxygen Reactivity of a Copper(I)
Complex Supported by a Tripodal Tetraamine Ligand
5 of 10
Semagenesis in Nonparasitic Plants
6 of 10
SYNTHESIS OF CYCLOPROPANES AND DIHYDROFURANS BY METAL CARBENOID
REACTIONS
7 of 10
Photoreleasable dynamic interfaces to control hybrid
cell-supported lipid membrane junctions
8 of 10
Rhodium(II)-Catalyzed Asymmetric Transformations and Their
Applications in The Development of Novel CNS Drug Candidates
9 of 10
Use of Receptor-Based Drug Design and Applications in the Study
of finding antagonists for MD-2/TLR4, GLP and CXCR4